Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.
| Symbol | ALUR |
|---|---|
| Exchange | OTC |
| Sector | Healthcare |
| Industry | Medical - Devices |
| CEO | Shantanu K. Gaur |
| Employees | 134 |
| Headquarters | Natick, MA, US |
| IPO | 2021-03-29 |
| Website | www.allurion.com |